Mineralys Therapeutics, Inc.'s total assets for Q4 2023 were $251.64M, a decrease of -9.34% from the previous quarter. MLYS total liabilities were $10.48M for the fiscal quarter, a -22.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.